MESTAG THERAPEUTICS
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
MESTAG THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.mestagtx.com
Total Employee:
1+
Status:
Active
Total Funding:
11 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Google Maps Google Google Maps API Google Cloud Microsoft Google Maps For Work
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Ray Therapeutics
Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Seed Round - Mestag Therapeutics
SV Health Investors
SV Health Investors investment in Seed Round - Mestag Therapeutics
Official Site Inspections
http://www.mestagtx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mestag Therapeutics"
Mestag Therapeutics » Signaling a new era in immunotherapy
At Mestag, we are developing critically needed new therapies that harness fibroblast immunology to re-establish the immune system’s proper function for patients who do not benefit from …See details»
About - Mestag Therapeutics
Mestag is an immunotherapy company, harnessing new insights into fibroblast-immune cell interactions to develop innovative treatments for cancer and inflammatory diseases.See details»
Mestag Therapeutics - Crunchbase Company Profile
View contacts for Mestag Therapeutics to access new leads and connect with decision-makers. Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology. A bispecific antibody …See details»
Life at Mestag - Mestag Therapeutics
We frequently hold Town Halls and team lunches, and have an active social committee, organizing regular events and ‘giving back’ activities supporting charities close to our hearts. …See details»
Mestag Therapeutics - Overview, News & Competitors - ZoomInfo
Mestag Therapeutics contact info: Phone number: +32 24256250 Website: www.mestagtx.com What does Mestag Therapeutics do? Mestag Therapeutics is a company that operates in the …See details»
Mestag Therapeutics - LinkedIn
Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for inflammatory disease and cancer. Through our unique understanding of fibroblast immunology, we are...See details»
Mestag Therapeutics - LinkedIn
Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we …See details»
Mestag Therapeutics - VentureRadar
Website: https://mestagtx.com/ Pioneers innovative treatments by modulating fibroblast-driven immune interactions to enhance anti-cancer activity and reduce inflammatory disease …See details»
Patrice Love - VP & Head of People & Culture at Mestag ... - The Org
Patrice is a specialist in human resources, operations, and organizational development, with particular experience in early–stage, high–growth businesses in life sciences, MedTech, and …See details»
Mestag Therapeutics Information - RocketReach
Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we …See details»
Contact - Mestag Therapeutics
If you are interested in collaborating with us to discover the full potential of fibroblast biology to bring new treatments to patients, please contact [email protected].See details»
Mestag Therapeutics launches with seed financing of $11 million …
Cambridge, UK, 20 April 2021 – Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced its launch with $11 million seed …See details»
Fierce Biotech Names Forbion Portfolio Company Mestag …
Cambridge, UK, 27 September 2021 – Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced that Fierce Biotech …See details»
Forbion Leads €28.6million Seed Extension Financing for Mestag ...
Aug 3, 2021 · Naarden, The Netherlands, 3 August 2021 – Forbion, a leading European life sciences venture capital firm, today announces the closing of an oversubscribed Seed …See details»
Mestag Therapeutics Extends Seed Financing to $45 Million and …
Cambridge, UK, 3 August 2021 – Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced the closing of its oversubscribed …See details»
Mestag Therapeutics | Insights
Oct 7, 2024 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Mestag Therapeutics · GitHub
Biotech startup, newly formed to explore emerging understanding of fibroblast subpopulations as targetable drivers of disease. This organization has no public members. You must be a …See details»
Mestag Therapeutics announces collaboration with Janssen, …
Cambridge, UK, 18 May 2021 – Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced a target discovery, option and …See details»
Mestag Therapeutics Company Information - Funding, Investors, …
Jan 1, 2021 · Get information on funding, investors, industries, and more for Mestag Therapeutics. See Mestag Therapeutics company profile and funding data.See details»
4T 1 monocul tur e - Mestag Therapeutics
Here we present a human bispecific antibody, M300, which conditionally agonizes LTBR in the tumor on co-engagement with fibroblast activation protein (FAP), a tumor microenvironment …See details»